The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
N-21
calcium fluoride, silicon dioxide, euphrasia stricta, ruta graveolens whole, gelsemium sempervirens whole, physostigma venenosum whole, anemone pulsatilla, sodium chloride, and sus scrofa eye · CALCIUM FLUORIDE 6 [hp_X]/mL; SILICON DIOXIDE 6 [hp_X]/mL; EUPHRASIA STRICTA 6 [hp_X]/mL; RUTA GRAVEOLENS WHOLE 6 [hp_X]/mL; GELSEMIUM SEMPERVIRENS WHOLE 6 [hp_X]/mL; PHYSOSTIGMA VENENOSUM WHOLE 4 [hp_X]/mL; ANEMONE PULSATILLA 8 [hp_X]/mL; SODIUM CHLORIDE 12 [hp_X]/mL; SUS SCROFA EYE 200 [hp_X]/mL · Solution · Sublingual · DNA Labs, Inc.
NDC 58264-0219-01 · 29.57 mL in 1 BOTTLE, GLASS · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of calcium fluoride, silicon dioxide, euphrasia stricta, ruta graveolens whole, gelsemium sempervirens whole, physostigma venenosum whole, anemone pulsatilla, sodium chloride, and sus scrofa eye (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| DNA Labs, Inc. | CALCIUM FLUORIDE 6 [hp_X]/mL; SILICON DIOXIDE 6 [hp_X]/mL; EUPHRASIA STRICTA 6 [hp_X]/mL; RUTA GRAVEOLENS WHOLE 6 [hp_X]/mL; GELSEMIUM SEMPERVIRENS WHOLE 6 [hp_X]/mL; PHYSOSTIGMA VENENOSUM WHOLE 4 [hp_X]/mL; ANEMONE PULSATILLA 8 [hp_X]/mL; SODIUM CHLORIDE 12 [hp_X]/mL; SUS SCROFA EYE 200 [hp_X]/mL | Aug 26, 2026 | Sep 2, 2026 |
| DNA Labs, Inc. | CALCIUM FLUORIDE 8 [hp_X]/mL; SILICON DIOXIDE 6 [hp_X]/mL; EUPHRASIA STRICTA 6 [hp_X]/mL; RUTA GRAVEOLENS WHOLE 6 [hp_X]/mL; GELSEMIUM SEMPERVIRENS WHOLE 4 [hp_X]/mL; PHYSOSTIGMA VENENOSUM WHOLE 6 [hp_X]/mL; ANEMONE PULSATILLA 6 [hp_X]/mL; SODIUM CHLORIDE 12 [hp_X]/mL; SUS SCROFA EYE 200 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| DNA Labs, Inc. | ANEMONE PULSATILLA 8 [hp_X]/mL; CALCIUM FLUORIDE 6 [hp_X]/mL; EUPHRASIA STRICTA 6 [hp_X]/mL; GELSEMIUM SEMPERVIRENS WHOLE 6 [hp_X]/mL; PHYSOSTIGMA VENENOSUM WHOLE 4 [hp_X]/mL; RUTA GRAVEOLENS WHOLE 6 [hp_X]/mL; SILICON DIOXIDE 6 [hp_X]/mL; SODIUM CHLORIDE 12 [hp_X]/mL; SUS SCROFA EYE 200 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "N-21 — NDC 58264-0219-01," retrieved September 3, 2026, https://drugdashboards.com/drug/58264021901.
Free to cite with attribution — see how the data is put together.